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Abstract
For years it has been clear that plasminogen from different sources and enolase from different sources interact strongly.
What is less clear is the nature of the structures required for them to interact. This work examines the interaction between
canine plasminogen (dPgn) and Streptococcus pyogenes enolase (Str enolase) using analytical ultracentrifugation (AUC),
surface plasmon resonance (SPR), fluorescence polarization, dynamic light scattering (DLS), isothermal titration calorimetry
(ITC), and simple pull-down reactions. Overall, our data indicate that a non-native structure of the octameric Str enolase
(monomers or multimers) is an important determinant of its surface-mediated interaction with host plasminogen.
Interestingly, a non-native structure of plasminogen is capable of interacting with native enolase. As far as we can tell, the
native structures resist forming stable mixed complexes.
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Introduction
The idea that there are components on the cell surface that bind
plasminogen and result in its activation to plasmin was put forward
by Miles and Plow in 1985 [1]. The cell surfaces in question were
mammalian and the original observation dealt with platelets. It
was clear from the outset that there was more than one receptor
on the cell surface and the identity of these receptors was soon
established [2]. Amongst the mammalian cell surface molecules
that can potentially bind plasminogen are the gangliosides [3] as
well as a-enolase [4–10] and glyceraldehyde-3-phosphate dehy-
drogenase [11].
Pathogenic bacteria also have mechanisms for activating
plasminogen, such as the secretion of streptokinase or staphloki-
nase [12,13]. In addition, some pathogenic bacteria and
eukaryotic parasites have cell surface molecules that can bind
plasminogen; the binding, in this case, might serve an insidious
role. If binding by a cell surface molecule on a pathogen can result
in activation of plasminogen to plasmin, then the binding-
activation event might help disseminate the infection [14,15].
For many of these bacteria, enolase has been identified as a cell
surface plasminogen receptor [13,15–41]; the binding of plasmin-
ogen and similar proteins to enolases from Streptococci has been
studied in detail [13,24,33,36,42–45].
Plasminogen is universally present in the blood of mammals. In
solution it is a monomeric protein composed of an N-terminal
peptide, followed by five kringle domains, followed by a
preproteolytic domain [46]. The N-terminal domain is non-
covalently associated with kringle 5 to form a structure which
doubles back on itself like a string of beads. There are partial X-
ray or NMR structures of the components of plasminogen but no
complete structure.
In contrast we know significantly more about the structure of
the enolase used here. Enolases from Streptococci are homo-
octamers in which the monomer consists of about 435 amino
acids. The eight identical subunits are arranged as a tetramer of
dimers. The crystal structure of the enolase from S. pneumoniae is
shown in Figure 1 (1W6T.pdb) [44]. Based on small molecule
studies, each monomer contains two potential binding sites for
plasminogen (Fig. 1). One site consists of the two C-terminal
lysines, coloured red in Figure 1; the second, coloured orange,
consisting of residues 248–256, is on an exposed loop (Figure 1).
The sequence of this loop, including the presence of two lysines,
seems to vary among the Streptococci [13].
All the work reported here has been done on the octameric protein
from S. pyogenes. Lysines 252 and 255, on an internal loop, and the C-
terminal lysines, 434 and 435, are required for binding [47]. A
homology model, based on the S. pneumoniae structure is available [47].
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ogen (dPgn) and native, solution phase, enolase from Streptococcus
pyogenes (Str enolase) and have not been able to demonstrate
that one protein will bind to the other. What is there that is
different about our studies that distinguishes them from the
others? We have been able to demonstrate binding when one of
the proteins is not in a soluble, native conformation. In this report
we establish under what conditions binding will occur and we
establish some of the characteristics of the species that are
involved.
Results
Four forms of native Str enolase were used in this study. Unless
otherwise stated, experiments were performed using the doubly
mutated form of Str enolase, F137L/E363G; this protein
contained an N-terminal hexa-histidine-tag. The three other
variants used were: (1) wild type enolase with no tag, (2) wild type
enolase with an N-terminal hexa-histidine tag, (3) wild type
enolase with C-terminal deca-histidine tag. Following purification,
all four were active, correctly folded according to their circular
dichroism spectra (not shown), and at least 90% octameric (as
determined by sedimentation velocity in the analytical ultracen-
trifuge, data not shown). We refer to protein with these
characteristics as ‘‘native’’.
Most experiments used canine plasminogen in its native closed
form.
We have applied the following techniques to determine when
and under what conditions Str enolase will bind to plasminogen:
fluorescence, isothermal titration calorimetry (ITC), dynamic light
scattering (DLS), analytical ultracentrifugation (AUC), pull down
reactions, and surface plasmon resonance (SPR). The critical
information that must be kept in mind is that the two proteins bind
under some circumstances and do not bind under others.
Understanding the difference between the two sets of conditions
is the thrust of this work.
Solution methods with native proteins
Three different techniques were used in which we could not
demonstrate an interaction between the two proteins: (1) dynamic
light scattering, (2) sedimentation velocity with the analytical
ultracentrifuge, and (3) fluorescence polarization. The experiments
were performed in buffers at pHs between 6.5 and 7.4 where we
knew the Str enolase was mainly octameric and the plasminogen
was in its native state. Various concentrations, up to 0.010 mM, of
the two proteins and various ratios were used; in no case was there
any evidence of an interaction. The results of the AUC experiment
are shown in Figure 2. There are no significant differences
between the sedimentation behavior of the individual proteins and
their sedimentation behavior in the mixture. The S20, w values are
precise to about 0.5%. In this case, there is no question but that
the two proteins do not interact on the time scale of the
experiment. The results of a DLS experiment are shown in
Table 1. DLS will not resolve differences between proteins whose
size differs by less than a factor of two. Accordingly, in the mixture
of dPgn and Str enolase the data resemble those of the Str enolase.
The significant aspect of the data in Table 1 is that there is not a
larger species that has formed on incubation of the two individual
native proteins.
Solution methods with non-native proteins
The above experiments were performed with dog plasminogen;
previous studies (see references in Introduction) used human
plasminogen. Could this be the reason for our failure to observe
binding? A fluorescently labeled, catalytically inactive, derivative
of human plasminogen (59IAF-Pg S741C) was tested for its ability
to bind to Str enolase; this protein was the generous gift of Dr
Figure 1. Structure of the octameric enolase. The identical subunits are arranged as a tetramer of A-B pairs. The color coding is: ‘‘A’’ subunits are
green and ‘‘B’’ subunits are yellow. The two putative plasminogen binding sites are shown. The first: only one atom of the C-terminal lysine-433 is
visible in the X-ray structure. It is coloured red. The adjacent leucine-432 is also coloured red for convenience of viewing. The second: the putative site
consists of residues 248–256. It is coloured orange. Figure 1A. Top down view showing the positions of the two sites. On the A subunits, the second
site is easily seen; it shows up on the B subunits when the molecule is flipped through 180u. Figure 1B. An end on view of the octamer. The orange
second site is clearly exposed whereas the red C-terminal is mostly buried.
doi:10.1371/journal.pone.0028481.g001
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Kingston, Ontario. Dr Nesheim died on June 4, 2011). The
fluorescent label was used to monitor the diffusion coefficient of
plasminogen; binding to enolase would result in a decreased
diffusion coefficient, due to the increase in size and, hence, an
increase in polarization. The results are shown in Table 2. The
first two lines of the table show that there is no detectable change
in polarization when the proteins have been maintained in their
native state at pH 6.7. As can be seen in Table 2, the polarization
of the human plasminogen was only changed when we lowered the
pH of the enolase solution to 4.5 and then diluted the enolase into
phosphate buffer, pH 6.7. At the submicromolar concentrations of
Str enolase used in this experiment, there was no problem with the
protein precipitating. Our reasons for performing this pH change
will soon be apparent. Under these conditions, there was a
significant increase in polarization of the human plasminogen,
indicating that binding of enolase had occurred. We concluded
that our failure to observe binding in the earlier experiments was
not due to using dog plasminogen; we also concluded that binding
involved non-native form(s) of Str enolase. It is interesting to note
that Antikainen et al. [48] observed that enolase bound to the cell
wall of Lactobacillus crispatus at pH 5 but not at higher pH. This
binding may also involve a non-native form of enolase that forms
at low pH.
Isothermal titration calorimetry (ITC) was also performed using
both native Str enolase and enolase treated at pH 9.0 (chosen to
mimic conditions of ELISA assays) or pH 4.5 (chosen to mimic
some aspects of SPR assays). The results are shown in Figure 3.
When both dPgn and Str enolase are maintained at pH 6.9, there
is no detectable binding (Figure 3A). When the enolase has been
incubated at pH 9.0 and then slowly returned to 6.9 (Figure 3B) or
treated at pH 4.5 and then returned to pH 6.9 (Figure 3C) binding
occurs. At the high concentrations required for the ITC
experiment, enolase treated at either pH 9.0 or 4.5 precipitated.
Following dialysis at pH 6.9, about 50% of the protein that had
been treated at pH 9.0 was recovered. Enolase treated at pH 4.5
remained insoluble after return to pH 6.9. It was therefore
solubilized in 27% (wt/wt) urea and dialyzed again at pH 6.9
before being used for the ITC experiment. 30% of the original
protein was recovered. In both cases, the specific activity of the
final enolase preparation used in the ITC experiments was only
30% of that of the original, untreated enzyme. The data are clear
and are consistent with the results of the fluorescence polarization
measurements. Binding does not occur when enolase is in its native
conformation. When enolase has been subjected to a treatment
that alters its conformation, and its enzymatic activity, as in going
from a native to a denatured state, there is the potential for
binding.
There is one condition to date in which we have seen binding
between native Str enolase, in solution, and dPgn. If dPgn is
treated with reductant, such as dithiothreitol (DTT), the dPgn
partially opens (as if it were a molten globule) and precipitates
[49]. The precipitation can be monitored by light scattering at
280 nm. Figure 4 shows the time course of precipitation of dPgn
by itself and in the presence of Str enolase. Str enolase, by itself,
does not precipitate; however, its presence increases the rate at
which dPgn precipitates. The samples from a similar experiment
were centrifuged and both the supernates and pellets subjected to
SDS-PAGE. As can be seen in Figure 5, the precipitates contain
both dPgn and Str enolase. When the ratio of dPgn to Str enolase
was 1:1, 12% of the precipitated protein was Str enolase,
corresponding to a dPgn:enolase ratio in the pellet of 6:1. When
the ratio in the initial incubation was 1:3, 25% of the precipitated
protein was Str enolase, giving a 3:1 ratio. A precipitating form of
dPgn binds native Str enolase that is in solution.
Binding between plasminogen and Str enolase in the
presence of a surface
A variety of label-free, real-time Surface Plasmon Resonance
(SPR) experiments were performed. Both F137L/E363G enolase
and plasminogen were coupled to SPR chips using amine
coupling. Preliminary screening of the Str enolase coated chip
showed that dPgn, Str enolase, fatty acid free bovine serum
albumin (BSA) and yeast enolase would bind to the coated surface
(Figure 6). Maltose binding protein (MBP) showed no significant
binding to the Str enolase coated surface. The dPgn coated chip
was also screened. Like the Str enolase chip, it bound dPgn, Str
Table 1. Stokes’ Radii of Str enolase, dPgn and their mixture.
Sample major species, hydrodynamic radius
dPgn 4.2 nm
99.9% mass






The protein radii were determined by dynamic light scattering using a Wyatt,
DynaPro apparatus thermostated at 20uC. Protein concentrations were kept at
levels which would give a maximum of 2E6 counts per second but always more
than 3E5 counts per second. The acquisition time was 10 seconds and 100
acquistions were collected. At least 95 of the 100 acquisitions were acceptable
in each evaluation.
doi:10.1371/journal.pone.0028481.t001
Figure 2. Analytical ultracentrifugation of Str enolase, dPgn,
and a mixture containing a ratio of 1 Str octamer:1 dPgn. The
solid black line is the combined Str enolase, dPgn mixture. The red line
is the Str enolase, and the green line is the dPgn. There is almost perfect
overlap between the red line and the Str enolase portion of the mix.
There is almost perfect overlap between the green line and the dPgn
portion of the mix. All proteins were ca 0.010 mM. The centrifuge speed
was 32, 000, 20uC. The data were analyzed using Sedfit.
doi:10.1371/journal.pone.0028481.g002
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(data not shown).
Next, a multi-cycle titration of the F137L/E363G coated chip
was performed with soluble, native dPgn (Figure 7A). The
association phase was monophasic. The dissociation phase
indicated that the off rate was about 10% of the on rate. The
steady-state amounts of dPgn bound indicated that the apparent
dissociation constant for the complex is in the submicromolar
range. It is important to note that coupling of Str enolase to the
amine based chip was performed at pH 4.5 (see Table 2) where
the electrostatic attraction between protein and chip was
experimentally determined to be strongest.
The dPgn coated chip was titrated with F137L/E363G Str
enolase (Figure 7B). The titration was significantly different from
that of F137L/E363G Str enolase titrated with dPgn. The
association phase was multi-phasic; the dissociation rate was very
slow and dissociation did not appear to go to completion. Half
saturation of all the association phases occurred at about 50 nM
Str enolase but this is number has no real meaning since the on
reaction is clearly multiphasic and the off reaction does not appear
to go to completion.
We also performed SPR using Ni-NTA coated chips; in these
experiments, the Str enolase was bound, at neutral pH, via a poly-
histidine tag. Three histidine-tagged Str enolase variants were
initially screened for their ability to bind to Ni
2+-activated NTA
sensors (Figure S1). The C-terminal His10-wild type Str enolase
showed the strongest binding followed by N-terminal His6-F137L/
E363G- Str enolase. N-terminal His6-wild type Str enolase did not
bind to any significant extent. As expected, there was no capture of
Table 2. Fluorescence polarization of Str enolase interacting with IAF-Pg S741C-hPgn.
Potential Ligand of IAF-Pg S741C-hPgn Treated first at pH and measured at pH 6.7 P (polarization)
None 6.7 0.3060.01
Str enolase 6.7 0.3060.01
Str enolase 4.5 0.4360.01
Fluorescently-labeled hPgn was used at a final concentration of 140 nM. Str enolase, when present, was 0.057 mM. The temperature was kept at 20uC. The Eclipse
fluorometer settings were: slits, 5 nm excitation and emission wavelengths were 470 nm and 516 nm respectively. The G factor was determined for each measurement.
All measurements were done five times; the spread between the calculated polarization values was never more than 60.01. The entire experiment was repeated one
time.
doi:10.1371/journal.pone.0028481.t002
Figure 3. Binding of plasminogen and enolase determined by
ITC. (A.) Native Str enolase was titrated into native dPgn. There was no
detectable binding. (B.) Str enolase was brought to pH 9. It precipitated
and was dialyzed to bring the pH back to pH 6.9. The protein loss was
about 50%. The remaining protein retained 30% enolase activity.
Enolase was titrated into dPgn. There were 0.18 sites available for
binding on the average enolase monomer. (C.) Str enolase was brought
to pH 4.5. It precipitated. The precipitate was dialyzed back to pH 6.9
and then dissolved in 27% urea (final) and then dialyzed again at
pH 6.9. Approximately 30% of the original enolase was recovered and
that retained about 30% of its specific activity. Enolase was titrated with
dPgn. This protein bound 0.34 dPgn per average monomer of Str
enolase.
doi:10.1371/journal.pone.0028481.g003
Figure 4. The influence of Str enolase on the precipitation
kinetics of dPgn. Each sample contained 0.2 M DTT. The bottom trace
(dash dot) contained 0.019 mM Str enolase but no dPgn. The solid trace
contained 0.002 mM dPgn but no Str enolase. The dotted trace
contained 0.002 mM dPgn and 0.0019 mM Str enolase. The top trace
(dash) contained 0.002 mM dPgn and 0.019 mM Str enolase. Under the
reducing conditions shown here, Str enolase enhances the rate at which
dPgn precipitates. In the absence of reductant, there is no precipitation
of the two proteins over a period of days.
doi:10.1371/journal.pone.0028481.g004
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no tag).
Figure 8A illustrates binding to the F137L/E363G coated chip
when challenged with dPgn, MBP or His-tag-free enolase. BSA
binding is not shown; it was similar to the tag-free enolase binding
at all concentrations. At low concentrations of dPgn, there is
significant binding to the immobilized enolase. Tag-free native
enolase, at low concentrations, also binds to the immobilized
enolase, but this is considerably less than the amount of dPgn that
binds. At high concentrations of ligand, the immobilized Str
enolase bound dPgn, tag-free enolase and BSA but not MBP. The
maximum observed binding of dPgn to the immobilized enolase
correlated well with the predicted binding maximum for a
stoichiometry of dPgn:enolase monomer=1:1 (see Methods).
Figure 8B illustrates binding to the chip when coated with C-
terminal His10-tag wild type enolase and then challenged with
dPgn, BSA, MBP or His-tag-free enolase. The same three proteins
bind in approximately the same ratios as with the N-terminally
tagged enolase. Native, octameric Str enolase should not, in our
opinion, bind additional enolase. This can only mean that the
enolases bound directly on the chip are, at least partially, not in
their ‘‘native’’ state.
We have maintained up to this point that binding between the
various partners occurs because the native structure of the proteins
is disrupted by the conditions leading up to binding. Can we
corroborate this idea with additional data? We used analytical
ultracentrifugation to report on the quaternary structure of the
Figure 5. Str enolase and dPgn co-precipitate in the presence
of reductant. SDS-PAGE of pellets and supernates from an experiment
similar to that described in Figure 4. The mixtures containing the
proteins and the reductant were centrifuged and the phases separated.
The upper and lower lanes 4 contain standards; 1:1 dPgn and Str
enolase (monomers); the top band is the 90 kDa dPgn and the bottom
is the 45 kDa Str enolase monomer. The lanes 1 show that dPgn
precipitates almost quantitatively in the presence of reductant. Lanes 2
shows that the precipitating dPgn pulls down enolase from a 1:1 mix of
dPgn and Str enolase monomer but the precipitation is not
quantitative. Lanes 3 show that the mixture which contains a 1:3 ratio
of dPgn to Str enolase monomer will pull down a significant fraction of
the Str enolase.
doi:10.1371/journal.pone.0028481.g005
Figure 6. Screening of amine coupled Str enolase with different
proteins. The F137L/E363G Str enolase coated chip was tested for
binding with 500 nM of each of the following proteins: (from top to
bottom) yeast enolase, Str enolase, dPgn, BSA and MBP.
doi:10.1371/journal.pone.0028481.g006
Figure 7. Titration of the amine coupled Str enolase with dPgn
(A) and the amine coupled dPgn with Str enolase(B). 7A. In the
top curve, the dPgn concentration was 500 nM. It was diluted 1:1 in
each successive descending curve. The bottom trace is the baseline. The
reaction appears to be totally reversible. 7B. Titration of amine coupled
dPgn with Str enolase The dPgn clearly binds enolase in a multiphase
reaction. The initial phase is very rapid and does not appear to be
reversible on the time scale of the experiment. The second phase
appears to be reversible. In the top curve, the Str enolase concentration
was 500 mM. It was diluted 1:1 in each successive descending curve.
doi:10.1371/journal.pone.0028481.g007
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sites of Str enolase were intact, and circular dichroism to report on
the secondary structure of the enolase.
Enolases at low pH
When diluted into acetate buffer, pH 4.0 or 4.5, F137L/E363G
enolase was inactive; in the AUC, there was a broad peak in
between that expected for octamers and monomers. No other
species were present. In other experiments, enolase precipitated
within minutes of being diluted into this buffer. Our results at low
pH were somewhat variable but it was clear that pH 4–4.5 treated
F137L/E363G enolase lost activity and lost its octameric
structure. Are the effects of this buffer treatment reversible?
Enolase was incubated at pH 4.5 for one hour and dialyzed
overnight against the buffer used in the SPR for the ligand
binding. Approximately 60% of the initial protein was recovered
in the soluble fraction of which 75% was monomeric and 19%
octameric. Its specific activity was 28% of the native but it
maintained 75% of the peptide bond CD signal. We conclude that
exposure of the S. pyogenes enolase to pH 4.0 or 4.5 buffer leads to
precipitation, dissociation and partial unfolding. These effects are
not fully reversible. As shown by SPR (Fig. 7), fluorescence
polarization (Table 2) and ITC (Fig. 3), acid treated protein binds
dPgn.
‘‘Native’’ enolases at neutral pH in SPR binding buffer
This buffer (see Materials and Methods) does not contain Mg
2+
but does contain EDTA. These conditions are known to
destabilize other enolases [50,51]. As shown in Table 3, the
various constructs of his-tagged Str enolase are all partially
dissociated in this buffer. There is a clear correlation between the
amount of enolase captured by the NTA sensor chip and the
percentage of the enolase that is monomeric in this buffer.
According to the X-ray structure of the S. pneumoniae enolase
(1w6t.pdb, [44]) the histidine tags point into the center of the ring
of subunits. The fact that the NTA sensor chip could bind F137L/
E363G enolase and wild type enolase with a C-terminal histidine
tag, but not the wild type enolase with an N-terminal tag suggests
to us that the N-terminal tag of the octamer is not accessible for
binding to the chip; the form of enolase binding to the Ni-NTA
chip is most probably monomeric.
Binding in the presence of phospholipid micelle surfaces
In addition to SPR, we assessed surface-mediated binding of
dPgn and Str enolase using liposome experiments. We adsorbed
Str enolase to phosphatidyl choline (soybean) micelles and
determined that, when centrifuged, plasminogen will cosediment
with the micelles as shown in the gels of Figure 9. The gels were
scanned and quantified. In both experiments, the majority of Str
enolase (64% in experiment 3, 94% in experiment 4) sedimented
with the micelles. The amount of dPgn, relative to the amount of
Str enolase, that co-sedimented was 1:1 to 1:1.2. Cosedimentation
of micelle and dPgn occurs only if enolase is also present; the
micelles, by themselves, do not bind dPgn. The supernates and
pellets were assayed for enolase enzymatic activity and the ability
of Pgn to convert to plasmin. Str enolase in the supernate was
active; it was also active in the pellet. dPgn in both supernate and
pellet was slowly activated by trypsin. After 24 hours, about 50%
of the dPgn in the pellet converted from glu-dPgn to lys-dPgn
while the remaining 50% converted to plasmin.
Discussion
We have posed the question: what is binding to what? We have
approached our question by asking what are the conditions that
promote the binding of Str enolase and plasminogen and what are
the conditions that do not promote binding. The answers to these
two questions have allowed us to sketch out a qualitative answer in
terms of the overall thermodynamics of binding and the overall
physiological importance of binding.
Figure 8. Binding of proteins to his-tagged Str enolase coupled
to Ni-NTA chips. Figure 8A. Different proteins binding to Ni-NTA
immobilized F137L/E363G Str enolase. The enolase was titrated with
dPgn (red), wt-Str enolase with no tag (black) and MBP (green). Each set
represents titration with 15 nM, 62 nM, 125 nM, 500 nM and 2000 nM
protein followed by washout. At the lower concentrations of titrating
protein there is some specificity for dPGN which disappears at higher
concentrations. Figure 8B. The wt-Str enolase was immobilized on Ni-
NTA via the carboxyterminal deca-his-tag. dPgn (red), wt-Str enolase
with no tag (black) and MBP (green) were flowed over the immobilized
protein at concentrations of 15 nM, 62 nM, 125 nM, 500 nM and
2000 nM. There is some specificity at the lower concentrations but not
at the higher. The two titrations are very similar but differ in the total
response and the response to low concentrations of titrant protein.
doi:10.1371/journal.pone.0028481.g008
Table 3. Quaternary Structure of Enolase in SPR binding
buffer as determined by AUC.
Enolase % octameric % monomeric
F137L/E363G 57 36
wild type, N-terminal tag 88 5
wild type, C-terminal tag 68 18
See Materials and Methods.
doi:10.1371/journal.pone.0028481.t003
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The native structures, plasminogen and Str enolase, are stable
and show little tendency to unfold. For binding of a partner to
occur, some degree of non-nativeness is necessary. For the
reaction,
Str enolase native octamer < Str enolase subunits <
Str enolase non  native subunits
equilibrium favours the octamer as we isolate it and work with it in
TME buffer. Our AUC experiments, however, indicate that
octameric enolase does not retain its integrity under conditions
such as the pH 4.5 treatments in our experiments, nor in the
presence of SPR binding buffer. The addition of native
plasminogen to native Str enolase does not perturb the equilibrium
in such a way that we can detect it using the many techniques
discussed here. DG for the overall reaction above is sufficiently
positive and the energy barriers for the interconversions are
sufficiently great that the addition of a potential binding partner
cannot pull the equilibrium towards the non-native state necessary
for binding. But, once the protein is converted to a non-native
state, via a pH change or other perturbation, the energy barriers
for proper refolding are sufficiently great that it does not occur on
the time scale of our experiments. The resultant conformational
changes in Str enolase favour its interaction with native
plasminogen, but also with other proteins, such as BSA, Str
enolase, and yeast enolase. Have we found any conditions in which
our two principle proteins will bind to one another in a native
state? The answer to the question is no. The closest we have come
to maintaining totally native proteins that still show binding is in
our SPR experiments using enolase bound to a Ni-NTA chip.
Here the hexa-his tag is at the N-terminus of the enolase or at the
C-terminus as a deca-his tag. For the hex-his, this protein will bind
plasminogen but it will also bind albumin and more importantly
Str enolase. The significance of this last point is that it must mean
that the species contains significant amounts of non-octamers.
Octamers show no tendency - that we can detect by AUC - to bind
octamers. For the C-terminal deca-his tag, the Str enolase binds
the same three proteins to about the same extent. In contrast to
other studies [47], our data show that, in these experiments at
least, C-terminal lysines are not required for binding. The two
different his-tagged proteins do not differ in their binding capacity
by a factor of more than three, even though the proteins must be
in different orientations on the chip. We consider that for dPgn
binding to Str enolase the data are clear. At least one of the
partners must be non-native in order for binding to occur.
We are not able to define the specific forms that bind, but we
can define the forms that do not bind. When both proteins are
soluble, correctly and completely folded and, in the case of
enolase, fully active, no binding occurs. Binding occurs in solution
when the enolase has been subjected to the treatments used in
SPR or ELISA experiments (Table 2, Figure 3). This enolase is a
mixture of forms - monomeric and octameric, folded and
unfolded, active and inactive; we do not know which form(s) bind
plasminogen. The most we can say about binding during the SPR
experiments that used amine coupling is that 1) very little, if any,
octameric, active enolase was present and 2) binding was relatively
non-specific, with Str enolase binding dPgn, BSA, yeast enolase
and itself.
The binding of his-tagged Str enolase to Ni-NTA chips was used
in SPR experiments in order to avoid the pH 4.5 treatment. The
binding is more specific, with binding of dPgn being greater than
that of more enolase or BSA. Based on the data in Table 3 and the
relative amounts of enolase that could be immobilized, this protein
is monomeric. The calculated stoichiometry of binding indicates
that all of these monomers are capable of binding dPgn. CD
spectra show that Str enolase in SPR buffer has normal secondary
structure. However, the fact that monomeric Str enolase is inactive
[52] means that there are some structural changes. We tentatively
conclude, therefore, that the form of Str enolase that is capable of
specific binding of dPgn is a folded monomer with an altered
conformation. What the structure is of the enolase bound to cells is
an open question at this time. We emphasize that, since bacteria
which have enolase on their surface are found in many different
environments, ranging from neutral to acidic, there may not be a
unique answer to this question.
We cannot generalize these results to all instances of enolase-
Pgn interactions, since, in other reports, information about the
structure of the enolase under the various experimental conditions
is lacking. Based on what is known about conditions that
destabilize the quaternary structure of yeast and mammalian
enolases [50,51] and the Str enolase used in these studies, it is
likely that the conditions used in SPR for coupling, for binding and
for regeneration of the chip [36,53] and conditions used in ELISA
experiments would not maintain the native structure of most
enolases. Our results with dPgn and Str enolase are similar to
those reported for Factor H and C-reactive protein [53]. No
binding between these proteins was observed when both were in
solution nor when the C-reactive protein was immobilized under
conditions that maintained its native structure. Binding was
observed only under conditions that destabilized the structure of
the C-reactive protein.
Is there a physiological relevance to the binding of the
two partners?
Are our results relevant to the proposed role of enolase during
bacterial infection? To date, nothing is known about the structure
of enolase when bound to cell surfaces, nor the mechanism by
which this cytoplasmic protein arrives at the cell surface. Several
Figure 9. Enolase adsorbed to the surface of phospholipid
micelles will bind dPgn. Azolectin (2 mg/mL) was suspended in
10 mM potassium phosphate, 100 mM NaCl, pH 7 and sonicated until
clear. Str enolase, when present, was added to 300 nM; dPgn when
present was 1000 nM. The first protein addition (Experiment 3: Str
enolase, experiment 4, dPgn) was made to the azolectin micelles and
the solution sonicated for another two minutes. The second protein
addition was made was made and the solutions incubated at 4uC for
three days (convenience timing). The samples were centrifuged at
20 000 rpm at 4uC for 2 hours. The phospholipids were extracted with
isopropanol, chloroform and the remaining material dissolved in SDS
sample buffer. The SDS-PAGE patterns of the pellets and supernates is
shown. Lane 1 contained Str enolase only. The micelles pull down the
enolase. Lane 2 contained dPgn only. The micelles do not pull down the
dPgn. Lanes 3/4 contained Str enolase and dPgn. The micelles pull
down the enolase which pulls down the dPgn.
doi:10.1371/journal.pone.0028481.g009
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bacterial cells. It has been proposed [55] that enolase is secreted,
by an unknown mechanism, and then binds to the surface of the
cells. Our experiments show that Str enolase binds to a
phospholipid micelle and can then bind dPgn. At this point, we
have no information about the structure of the enolase when
bound to the micelles. Our results, both with the micelles and with
the precipitating dPgn (Figures 4, 5 and 9), suggest that surfaces
play a role in the enolase-Pgn interaction; perhaps the interaction
of enolase with a surface produces a conformation of enolase
capable of Pgn binding.
Str enolase and the other enolases found on cell surfaces will
bind plasminogen but will also bind other proteins. A pathogen
with surface enolase in the blood of a host is confronted with
0.002 mM plasminogen but also with ca. 0.500 mM albumin!
When the number of enolase sites on the pathogen is large, there
will be some plasminogen binding to the pathogen’s enolase; how
many plasminogens vs albumins will be determined by the relative
binding coefficients and concentrations. The bound plasminogen
could, when activated to plasmin, promote the dissemination of
the infectious particles. More importantly, bound surface albumin
or Pgn [56] might very well disguise the pathogen thereby allowing
it to escape detection by the host’s immune system. What is clear is
that the surface enolase can bind a significant number of different
species and these species likely determine the overall physiological
outcome of the binding. A final complication in evaluating the
physiological importance of this interaction is that it is also
observed in bacteria viewed as ‘‘friendly’’. Commensal microor-
ganisms that have been shown to have surface enolases that bind
plasminogen include oral streptococci [13], bifidobacteria [18]
and lactobacillus [57]. Does the enolase on the surface of these
bacteria have a physiological role or is its presence purely




The experimental protocol was approved by the Animal Ethics
Committee of the McGill University Health Centre Research
Institute and the McGill University Animal Ethics Committee, in
accordance with Canadian regulations for experimentation in
animals. Dogs were maintained within the Large Animal Facilities
of the MUHC-RI for the overall duration of experiments. The
Unit is certified for Good Animal Practice Care by the Canadian
Council on Animal Care. The animal work was carried out under
protocol number 5717.
Protein preparation and purification
The Str enolase gene, both wild type and the F137L/E363G
mutant, were maintained in the pET-14b plasmid. In order to
have a protein with a C-terminal histidine tag, the gene for the
wild type protein was transferred into pET-52b(+). Mutagenesis,
expression, purification using a Ni-NTA column under non-
denaturing conditions and assays for enzymatic activity have been
described [52]. The cleavage of the C-terminal his-tag to yield the
Str enolase-WT was performed as follows: Thrombin (GE
Healthcare) was suspended in 140 mM NaCl, 10 mM Na2HPO4,
1.8 mM KH2PO4, 2.7 mM KCl. Purified enolase was incubated
with thrombin (1 unit thrombin per 0.001 mg protein) for 8 hours
at 15uC. The reaction was stopped by dialysis against the same
buffer; the cleaved mixture was contained within a membrane
with a 50 000 molecular weight cutoff through which the
thrombin could pass. The high molecular weight Str enolase
without the his-tag was passed through a 1 mL Ni-NTA column.
The fraction that did not bind, tag-free Str enolase, was dialyzed vs
TME.
The preparation of dPgn has been described [58]. Our standard
assay for dPgn activation to plasmin consists of incubating dPgn
with trypsin (40 nM), monitoring enzymatic activity using
Spectrozyme and monitoring the change in gel pattern as the
dPgn converts first to lys-dPgn and then to plasmin.
All five proteins were estimated to be .95% pure by SDS-
PAGE. The standard buffers used were:
1. TME, 50 mM Tris, 1 mM Mg(OAc)2,0 . 1 m ME D T A ,
pH 7.4.
2. Phosphate buffer, 5 mM KH2PO4, 5 mM K2HPO4, 100 mM
NaCl, pH 6.7.
3. SPR precoupling buffer, 20 mM sodium acetate pH 4 to pH 5.
4. SPR binding buffer (amine coupled chips), 10 mM HEPES,
150 mM NaCl, 1.4 mM EDTA, pH 7.4.
All chemicals were of the highest quality available and were
purchased from Fluka Chemical Co., Sigma Chemical Co.,
Fermentas, Stratagene, or Pharmacia; Spectrozyme was from
American Diagnostica.
Dynamic light scattering was performed on a Wyatt Technology
Corp. DynaPro instrument equipped with temperature control.
Scattering was measured at 20uC in a 0.025 mL cuvet. Buffers and
samples were centrifuged for 5 minutes at 13,000 RPM in a
benchtop microfuge. A 0.040 mL aliquot was taken from the top
of the centrifugate and placed in the cuvet with a Hamilton
syringe. Water and buffer blanks contributed about 3E4 counts
per second. Samples containing protein contained a sufficient
concentration to give about 2E6 counts per second. Data were
collected for 10 seconds per acquisition; 100 acquistions were
collected. At least 95% of the acquisitions were of acceptable
quality. Data were evaluated using the Wyatt software. Occasion-
ally we checked the results qualitatively using Sedfit.
Sedimentation velocity experiments were performed in a Beckman
XL-I analytical ultracentrifuge at 32 000 rpm at 20uC and
monitored at either 280 and or 230 nm. The partial specific
volume of the proteins, solvent density and viscosity were
calculated by SEDNTERP, version 1.07 (D.B.Hayes, T. Laue
and J. Philo, available at www.bbri.org/RASMB/rasmb.html) and
the results were analyzed with the Sedfit program [59,60].
Fluorescence polarization was performed on a Cary Eclipse
fluorometer equipped with an automatic polarizer attachment.
The function of the polarizers was verified using a light scatterer
(dilute milk) as standard.
Isothermal titration calorimetry was performed using a Microcal VP-
ITC calorimeter thermostated at close to 20uC. The protein
solutions were dialyzed against three buffer changes. The data
were analyzed using Origen software provided by Microcal.
Baselines required adjusting in all cases and were treated using the
same software. Rigorous thermodynamic parameters were not
calculated because the concentrations of the various species in
solution, after the different pH treatments, could not be
determined.
Circular dichroism (CD) spectra were measured at 15uC with a
Jasco J-810 spectropolarimeter. For each protein sample its buffer
solution was scanned to obtain the baseline. Samples were scanned
5 times with the response time of 1 second and bandwidth of 1 nm
from 260 to 200 nm at a scan rate of 20 nm/min. The Spectra
Manager program (Jasco) was used to subtract the baseline and
smooth the spectra. Spectra of the native enolases were assessed in
Plasminogen-Enolase Interactions
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buffer.
‘‘Pull down’’ reactions were of two types: (1) DTT induced
precipitation and the course of the reaction followed at 280 nm
have been described [49] and (2) adsorption of Str enolase and
dPgn to phosphatidyl choline micelles. In the latter case, azolectin
(2 mg/mL) was suspended in 10 mM potassium phosphate,
100 mM NaCl, pH 6.7 and sonicated until clear. Str enolase,
when present, was 300 nM; dPgn, when present, was 1000 nM.
The first protein addition was made to the azolectin micelles and
the solution sonicated for another two minutes. The second
protein addition was made and the solutions incubated at 4uC for
three days (convenience timing). The samples were centrifuged at
20 000 rpm at 4uC for 2 hours. The phospholipids were extracted
with isopropanol/chloroform and the remaining material dis-
solved in SDS sample buffer. The samples were analyzed by SDS-
PAGE. The developed gels were scanned and quantified with
ImageJ, available from NIH.
Surface plasmon resonance was performed on a BIACORE 3000
instrument (GE Healthcare Bio-Sciences AB, Upsala, Sweden).
Amine-coupled experiments were performed on CM4 sensor chips
at 25uC. Alternatively, Ni-NTA chips were used to assay binding
by the hexa-his or deca-his tagged Str enolases. Initially, F137L/
E363G Str enolase (5 mg/mL in 20 mM sodium acetate pH 4.5)
was directly immobilized to CM4 sensor chips using the Biacore
Amine Coupling Kit (,260 Resonance Units (RU) final);
corresponding reference surfaces were prepared in the absence
of enolase. Purified dPgn, bovine serum albumin (BSA), Maltose
Binding Protein (MBP), yeast enolase, or Str enolase were injected
(500 nM each) over reference and randomly-oriented Str enolase
surfaces (30 mL/min65 min association+5 min dissociation). Be-
tween sample injections, sensor chip surfaces were regenerated at
50 mL/min using two 30-second pulses of running buffer
containing 1 M NaCl, 10 mM NaOH, and 0.5% (v/v) Empigen)
and Pierce Gentle Elution buffer containing 0.5% (v/v) Empigen.
dPgn was then titrated (0–500 nM; 2-fold dilution series) in a
similar manner over Str enolase-immobilized surfaces (0.030 mL/
min65 min association+10 min dissociation). In reciprocal exper-
iments, Str enolase was titrated (0–500 nM; 2-fold dilution series)
over reference and amine-coupled dPgn surfaces (0.005 mg/mL in
20 mM sodium acetate pH 4.5; 340 RU immobilized to CM4
sensors).
To complement the direct amine-coupled experiments, Str
enolase variants were indirectly captured to NTA-coated sensor
chips to (i) avoid the acidic immobilization conditions and (ii)
create homogenous, oriented surfaces. Initially, the four different
Str enolase variants (each diluted to 100 nM in the presence of
250 mM NaCl and 10 mM imidazole) were injected over
activated NTA surfaces to compare their capture efficiencies
under identical assay conditions. To ensure that each variant was
stably bound, post-capture surfaces were washed at 0.05 mL/min
using two 30-second pulses of 10 mM HEPES, 500 mM NaCl,
10 mM Imidazole, and 0.05% (v/v) Empigen, followed by 10 mM
HEPES, 150 mM NaCl, 0.05 mM EDTA and 0.005% (v/v)
Empigen. Surfaces were considered stable if there was no
significant dissociation over 180 sec post-washing. Between sample
injections, sensor chip surfaces were regenerated at 0.050 mL/min
using two 1-min pulses of Pierce Gentle Elution solution
containing 0.1% (v/v) Empigen followed by 200 mM imidazole,
and finally 350 mM EDTA. Subsequently, single-cycle titrations
were performed using NTA-captured Str enolase surfaces: N-
terminal His-tagged F137L/E363G and C-terminal His-tagged wt
Str enolase (,150 RU of each variant captured per cycle). dPgn,
tag-free Str enolase, MBP, and BSA were injected (0–2000 nM; 4-
fold dilution series) over NTA reference and Str enolase-captured
surfaces (0.010 mL/min65 min association+1–10 min dissocia-
tion); between sample cycles, surfaces were regenerated as noted
above.
All SPR data were doubled-referenced [61] and is representa-
tive of duplicate injections acquired from two independent trials.
For the amine-coupled experiments, a buffer blank was injected at
the start of each multi-cycle titration, the highest titrant
concentration second, and serial dilutions followed (from the
lowest to the highest concentration). Comparing responses
between the two highest titrant injections verified consistent
immobilized surface activity throughout each assay. Steady-state
binding responses (RU at end of association phase) were plotted as
a function of titrant concentration; apparent equilibrium dissoci-
ation constants (KD) were determined by global fitting of the data
to a ‘‘steady-state affinity’’ model (BIAevaluation v4.1 software).
For the NTA experiments, the single-cycle titrations were fit to a
‘‘1:1 Titration’’ model in the BIAevaluation software [62].
Theoretical binding maxima were predicted using the following
equation: Rmax=(MWA/MWL)( R L) (n); ‘Rmax’ is the theoretical
maximal binding response (RU) at saturating titrant concentra-
tion, ‘MWA’ is the molecular weight of the titrant injected in
solution, ‘MWL’ is the molecular weight of the immobilized
biomolecule, ‘RL’ is the amount (RU) of biomolecule immobilized,
‘n’ is the predicted binding stoichiometry (e.g. 1:1).
Supporting Information
Figure S1 Screening for the capture of protein on a Ni-NTA
sensor chip. The proteins flowed over the chip were dPgn (solid),
N-terminal Hexa-histidine F137L/E363G (dots), Hexa-histidine
wt (dash) and Deca-histidine wt (dash dot). Additionally, the chip
was challenged with NaCl and the deca-histidine cleaved enolase;
these, like the dPgn, did not stick to any significant extent. Prior to
second 400, the chip was washed with EDTA and NiSO4. Ligand
capture occurred during phase III. Phase IV was a high salt wash
and phase V was a buffer wash.
(TIF)
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